Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: Anheuser-Busch InBev NV Gets the Party Started


Wall Street ratings agencies set the tone for today's stock market.

June 13 was the birthday not only of history's greatest Sherlock Holmes but also an iconic English mystery writer. Yet both would have been dumbfounded by the market's latest whodunit.

Only twenty-four hours after shares slumped amid ominous talk about the "r" word and the "s" word, stocks bounced back spectacularly to score their second best day of all 2013. Its first gain of the week took the Dow (^DJI) back above 15,000, although there were still some notable losers.

Microsoft Corporation (MSFT), whose founder once famously took a pie in the eye, was the poorest performing blue chip in ending off 0.81%. Meanwhile Rupert Murdoch filed for divorce from his wife, who once heroically fended off a pie aimed his way. Amid such matrimonial woe, little wonder wedding band behemoth Tiffany & Co. (TIF) tumbled 1.72%, its stock now arguably as big a steal as today's big movie opening, The Bling Ring.

And perfume stock Coty Inc. (COTY) - whose Lady Gaga fragrance was described by the pop star as having the aroma of "an expensive hooker" - stopped making cents, falling 14 pennies in its much-anticipated market debut.

Today in economics, June's Thomson Reuters/University of Michigan consumer sentiment index will be released at 9:55 a.m. EDT. (Or 9:54:58 a.m. EDT, if you are among the favored few to get it two seconds early.) On the corporate front, American Superconductor (AMSC), Magnum Hunter (MHR) and Smithfield Foods (SFD) report results.

Air Products & Chemicals, Inc (APD): Shares are established with an Outperform at Raymond James.

Anheuser-Busch InBev NV (BUD): JPMorgan begins the brewing behemoth at a bullish Overweight.

Automatic Data Processing Inc. (ADP): The stock is initiated with an Outperform at Raymond James.

Auxilium Pharmaceuticals, Inc. (AUXL): Shares are assigned a Buy rating and $28 price objective at Mizuho, which sees FDA (Food and Drug Administration) approval of Xiaflex to treat Peyronie's in September, after which a robust roll out is anticipated.

British Banks: Jefferies has a Hold on Lloyds Banking Group PLC (LYG) and resumes Buy-rated research on Royal Bank of Scotland Group plc (RBS).

Freeport-McMoRan Copper & Gold Inc. (FCX): The commodity company is a fresh Outperform at Credit Suisse.

NewLink Genetics Corp (NLNK): Jefferies has a new Buy on NLNK.

MB Financial, Inc. (MBFI): The stock is initiated with a Buy and $30 objective at DA Davidson, which highlights strong capital and profitability metrics.

Praxair, Inc. (PX): Raymond James picks up the chemical company at a Strong Buy.

The Ensign Group, Inc. (ENSG): Cantor Fitzgerald covers the long-term care company at a Buy amid good acquisition growth and new market penetration. Its target price is $40.

(See also: Stock Upgrades: Groupon Inc Is Today's Deal of the Day and Stock Downgrades: E I Du Pont De Nemours and Co Loses That Teflon Touch.)
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos